(S, R) -CFT8634
(S, R) -CFT8634 (compound 176) is a selective and orally active PROTAC-class BRD9 protein degrader. (S, R) -CFT8634 has the potential to study BRD9-mediated diseases, including but not limited to abnormal cell proliferation. (S, R) -CFT8634 consists of a target protein ligand (red part) BRD9 ligand-5 , an E3 ligase ligand (blue part) CRBN ligand-11 (HY-169989), and a PROTAC linker (black part) 1- (3,3-Difluoro-4-piperidinyl) piperazine (HY-169991). E3 ligase ligand and linker can form E3 Ligase Ligand-linker Conjugate 142 (HY-169990).
Product Specifications
CAS Number
2704617-95-6
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/s-r-cft8634.html
Solubility
10 mM in DMSO
Smiles
CC(C(C1=CC(OC)=C(C(OC)=C1)CN2CC(F)([C@@H](N3CCN(C4=C(C=C(C=C4)N[C@H]5C(NC(CC5)=O)=O)F)CC3)CC2)F)=CN6C)=C(C)C6=O
Molecular Formula
C37H45F3N6O5
Molecular Weight
710.79
References & Citations
[1]Christopher G. Nasveschuk, et al. Compounds for targeted degradation of brd9. Patent WO2021178920A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EGLN1 / PHD2 (366G/76/3), CF740 conjugate, 0.1mg/mL
Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (rKRT16/1714), CF405S conjugate, 0.1mg/mL
